AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 213 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $4,058,000 | -40.2% | 88,000 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $6,787,000 | -80.8% | 88,000 | -79.0% | 0.00% | -75.0% |
| Q2 2018 | $35,377,000 | +3.0% | 420,000 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $34,348,000 | -9.4% | 420,000 | -36.7% | 0.01% | 0.0% |
| Q4 2017 | $37,904,000 | -14.4% | 663,000 | 0.0% | 0.01% | -20.0% |
| Q3 2017 | $44,255,000 | +29.7% | 663,000 | 0.0% | 0.01% | +25.0% |
| Q2 2017 | $34,111,000 | -11.9% | 663,000 | 0.0% | 0.01% | -11.1% |
| Q1 2017 | $38,719,000 | +39.9% | 663,000 | 0.0% | 0.01% | +28.6% |
| Q4 2016 | $27,667,000 | -21.0% | 663,000 | 0.0% | 0.01% | -22.2% |
| Q3 2016 | $35,020,000 | -59.7% | 663,000 | -68.1% | 0.01% | -60.9% |
| Q2 2016 | $86,995,000 | -31.7% | 2,076,491 | -33.8% | 0.02% | -34.3% |
| Q1 2016 | $127,326,000 | -37.5% | 3,136,120 | 0.0% | 0.04% | -38.6% |
| Q4 2015 | $203,597,000 | -4.8% | 3,136,120 | +3.5% | 0.06% | -9.5% |
| Q3 2015 | $213,967,000 | -39.3% | 3,031,120 | -4.4% | 0.06% | -34.4% |
| Q2 2015 | $352,438,000 | +18.4% | 3,171,120 | +0.4% | 0.10% | +20.0% |
| Q1 2015 | $297,716,000 | -14.3% | 3,157,120 | +1.9% | 0.08% | -14.9% |
| Q4 2014 | $347,212,000 | +399.9% | 3,098,997 | +173.7% | 0.09% | +370.0% |
| Q3 2014 | $69,456,000 | +33.9% | 1,132,120 | 0.0% | 0.02% | +42.9% |
| Q2 2014 | $51,874,000 | +295.5% | 1,132,120 | +237.9% | 0.01% | +250.0% |
| Q1 2014 | $13,115,000 | +281.0% | 335,000 | +133.1% | 0.00% | +300.0% |
| Q4 2013 | $3,442,000 | +75.9% | 143,700 | +105.3% | 0.00% | 0.0% |
| Q3 2013 | $1,957,000 | – | 70,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
| Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
| Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
| BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
| Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
| Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
| Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
| BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
| Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
| HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |